As of 2025-09-17, the Intrinsic Value of Revive Therapeutics Ltd (RVV.CN) is -0.04 CAD. This RVV.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.02 CAD, the upside of Revive Therapeutics Ltd is -338.90%.
Based on its market price of 0.02 CAD and our intrinsic valuation, Revive Therapeutics Ltd (RVV.CN) is overvalued by 338.90%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.04 - -0.04 | -0.04 | -338.90% |
| DDM - Stable | (0.09) - (0.68) | (0.38) | -2648.1% |
| DDM - Multi | (0.00) - (0.01) | (0.00) | -123.3% |
| Market Cap (mil) | 8.37 |
| Beta | 2.65 |
| Outstanding shares (mil) | 558.09 |
| Enterprise Value (mil) | 8.39 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.31% |
| Cost of Debt | 5.00% |
| WACC | 7.30% |